好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Dosing Patterns During Conversion to IPX066, Extended-Release Carbidopa-Levodopa, from Other Carbidopa-Levodopa Formulations in Advanced Parkinson’s Disease Patients
Movement Disorders
(-)
338
Authors/Disclosures
John C. Morgan, MD, PhD (Augusta University)
PRESENTER
Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Morgan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Civil Cases. Dr. Morgan has received personal compensation in the range of $5,000-$9,999 for serving as a Rater with Praxis.
Mark Stacy, MD (MUSC Department of Neurology) Dr. Stacy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Stacy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institute of Aging. Dr. Stacy has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Dartmouth. Dr. Stacy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal.
Robert P. Rubens, MD, MBA, FAAN, FAAN (NeuroDevMA Consulting, Inc.) Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals.
No disclosure on file
Suneel K. Gupta, PhD No disclosure on file